Status:
UNKNOWN
A Multi-Omics Study of Vasospastic Angina
Lead Sponsor:
Tongji Hospital
Conditions:
Vasospastic Angina
Eligibility:
All Genders
18+ years
Brief Summary
This is a observational study to identify the key factor associated with vasospastic angina and to explore the prognosis of the participants. The study will recruit 400 patients with vasospastic angin...
Eligibility Criteria
Inclusion
- 18 years of age or older
- diagnosed as vasospastic angina
Exclusion
- participate in any drug clinical trials within 3 months
- patients with life-threatening complications, or the researchers determined that the survival time of patients with no more than 1 years
- serious neurological disease (Alzheimer's disease, Parkinson syndrome, progressive lower limbs or deaf patients)
- previous history of cancer or tumor, or pathological examination confirmed precancerous lesions (such as breast ductal carcinoma in situ, or atypical hyperplasia of the cervix)
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05282511
Start Date
January 1 2012
End Date
December 1 2022
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430030